TrialCephalalgia : an international journal of headache2020

Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).

Messoud Ashina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.